Not known Facts About azelaprag peptide
AMG 986 exposures increased nonlinearly with rising doses; negligible accumulation was observed. In HF with lessened ejection fraction clients, there have been numerical increases in % variations from baseline in LV ejection fraction and stroke volume by volumetric assessment with AMG 986 vs placebo